The Critical Challenge of Tracking Breakthrough Infections, and Why We Still Need Better Data Standards

Despite ample vaccine supplies, outbreaks among unvaccinated populations in the US and the appearance of the Delta variant promote infection in fully vaccinated individuals. These breakthrough infections must be carefully tracked. As the percentage of Americans considered…

Continue Reading The Critical Challenge of Tracking Breakthrough Infections, and Why We Still Need Better Data Standards

MIX AND MATCH

But with three options for initial adult vaccinations (J&J, Pfizer and Moderna) and three choices for boosters (J&J, Pfizer and Moderna), is there a ‘best’ option of vaccine + booster? Do you stick with the same…

Continue Reading MIX AND MATCH

Medicare Advantage’s cost to taxpayers has soared in recent years, research finds

Medicare Advantage health plans have enrolled nearly 27 million members, or about 45% of people eligible for Medicare. A recent analysis finds Medicare overpaid the private health plans by more than $106 billion from 2010 through…

Continue Reading Medicare Advantage’s cost to taxpayers has soared in recent years, research finds

Who is eligible for vaccine boosters

As the Advisory Committee on Immunization Practices last week approved the Pfizer COVID-19 vaccine for children aged 5-11, a significant swathe of the population previously susceptible to infection is now eligible for vaccination. Simultaneously, efforts to…

Continue Reading Who is eligible for vaccine boosters